Noticias de la SETH

 

Thrombotic and bleeding disorders are global disease burdens with considerable morbidity and high mortality. Estimates for the European Union (EU) suggested an annual death toll of 500,000 venous thrombosis (VT)-related deaths with a short-term mortality rate comparable to ischemic stroke. On another scale, about 1 in 300 persons is affected by an inherited bleeding disorder. Uncontrolled bleeding is a major healthcare issue not only among these patients but also among patients with an acquired bleeding disorder. Following-up on the previous addition of the EHA Roadmap, the following chapters will give you an overview and update on important developments and multidisciplinary aspects of hemostasis and thrombosis. Owing to the SARS-CoV-2 pandemic, we specifically focus on infections and coagulopathy. We will describe major needs and cutting-edge questions in basic and clinical research in this topic providing views on future developments.